Steven L. Flamm
Expertise in
23
conditions

Dr. Steven L. Flamm

Hepatology
RUSH Munster
9200 Calumet Ave, 
Munster, IN 
Accepting New Patients
Offers Telehealth
33 Years of Experience
Expertise in
23
conditions
RUSH Munster
9200 Calumet Ave, 
Munster, IN 

Overview

Steven Flamm is a Hepatologist practicing medicine in Munster, Indiana. He has been practicing medicine for over 33 years.

Dr. Flamm is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 4 clinical trials. Dr. Flamm is currently accepting new patients.

Specialties

Hepatology

Licenses

Internal Medicine in IL

Hospital Affiliations

Rush Oak Park Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 12 Less Insurance Carriers -

Locations

RUSH Munster
9200 Calumet Ave, Munster, IN 46321

Additional Areas of Focus

Dr. Flamm has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
Enrollment Status: Completed
Publish Date: June 29, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Enrollment Status: Completed
Publish Date: July 21, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

90 Total Publications

Alcohol-Related Liver Disease: Novel Insights into Mechanism.
Alcohol-Related Liver Disease: Novel Insights into Mechanism.
Journal: Clinics in liver disease
Published: November 20, 2025
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (17.4 miles away)
888-824-0200
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Rinella is a Hepatologist practicing medicine in Chicago, Illinois. Dr. Rinella is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Rinella is board certified in Gastroenterology Transplant Hepatology and Practicing Since2002. Dr. Rinella is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required
Before you request
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (24.5 miles away)
312-695-4837
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Laura Kulik is a Hepatologist practicing medicine in Chicago, Illinois. Dr. Kulik is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Hepatitis, Fibrolamellar Carcinoma, Liver Transplant, and Liver Embolization. Dr. Kulik is board certified in American Board Of Internal Medicine - Transplant Hepatology (Certified). Dr. Kulik is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral required
Before you request
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (24.5 miles away)
312-695-4837
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Andres Duarte is a Hepatologist practicing medicine in Chicago, Illinois. Dr. Duarte is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Duarte is board certified in American Board Of Internal Medicine - Gastroenterology (Certified). Dr. Duarte is currently accepting new patients.

Frequently Asked Questions about Dr. Steven L. Flamm

How do I make an appointment with Dr. Steven L. Flamm?

You can book an appointment with Dr. Steven L. Flamm by calling their office at 219-806-6585. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven L. Flamm a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven L. Flamm is classified as an Elite expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven L. Flamm specialize in?

While Dr. Steven L. Flamm is a Hepatology, they have specific expertise in Hepatitis C, Hepatitis, and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hepatology.

Does Dr. Steven L. Flamm participate in research or clinical trials?

Yes. Dr. Steven L. Flamm has published 90 articles and abstracts on conditions like Hepatitis C. You can view a list of Dr. Steven L. Flamm's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Steven L. Flamm accept my insurance?

Dr. Steven L. Flamm accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 219-806-6585 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Flamm's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 13 Advanced Conditions
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile